Immix Biopharma, Inc. logo

Immix Biopharma, Inc.

7 Marks
Corp.
First Filed:Jul 6, 2021Latest Filed:Feb 28, 2024Address:10573 W. Pico Blvd, #58, Los Angeles, CA 90064

Portfolio Overview

Registered
1(14%)
Dead
6(86%)

Top Classes

Class 5
Pharmaceuticals
6(86%)
Class 42
Software, IT Services & Scientific Research
3(43%)
Class 44
Medical, beauty and agricultural services
1(14%)

TTAB Proceedings

No litigation activity

Top Firms

AURA IP LAW(Feb 2024)
7

Trademark Portfolio

7 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
SMARXT
SMARXT
Trademark
Word
ABANDONED
Owner:
Serial:98426370
Filed:Feb 28, 2024
Classes:5, 42
Goods & Services
anti-cancer preparations; anti-cancer drugs; compounds for treating cancer; pharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical compositions for the treatment of cancer; pharmaceutical drugs for the treatment of cancer; pharmaceutical preparations for human use for the treatment of cancer; pharmaceutical preparations and substances for the treatment of treatment-resistant cancers biological preparations for the treatment of cancer; biological preparations for medical purposes for the treatment of cancer; medical preparations for the treatment of cancer; medicinal preparations and substances for the treatment of cancer; medicines for human purposes for the treatment of cancer; injectable pharmaceuticals for the treatment of cancer; compounds for treating resistant cancers; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for use in chemotherapy; anti-tumor preparations; anti-tumor drugs; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; preparations for treating malignant tumors; medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for treating gastrointestinal disorders; scientific research in the field of oncology; scientific research in the field of immuo-dysregulated diseases; development of pharmaceutical preparations and medicines for the treatment of cancer; development of pharmaceutical preparations and medicines for the treatment of immuno-dysregulated diseases; clinical research in the field of oncology; clinical research in the field of immuo-dysregulated diseases; research and development services in the field of anti-cancer preparations; research and development services in the field of preparations for treating immuno-dysregulated diseases; design, engineering, research, development and testing services in the field of oncology; design, engineering, research, development and testing services in the field of immuno-dysregulated diseases; providing information regarding medical research relating to oncology; providing information regarding medical research relating to immuno-dysregulated diseases
TSTX
TSTX
Trademark
Word
ABANDONED
Owner:
Serial:98426361
Filed:Feb 28, 2024
Classes:5, 42
Goods & Services
anti-cancer preparations; anti-cancer drugs; compounds for treating cancer; pharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical compositions for the treatment of cancer; pharmaceutical drugs for the treatment of cancer; pharmaceutical preparations for human use for the treatment of cancer; pharmaceutical preparations and substances for the treatment of treatment-resistant cancers biological preparations for the treatment of cancer; biological preparations for medical purposes for the treatment of cancer; medical preparations for the treatment of cancer; medicinal preparations and substances for the treatment of cancer; medicines for human purposes for the treatment of cancer; injectable pharmaceuticals for the treatment of cancer; compounds for treating resistant cancers; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for use in chemotherapy; anti-tumor preparations; anti-tumor drugs; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; preparations for treating malignant tumors; medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for treating gastrointestinal disorders; scientific research in the field of oncology; scientific research in the field of immuo-dysregulated diseases; development of pharmaceutical preparations and medicines for the treatment of cancer; development of pharmaceutical preparations and medicines for the treatment of immuno-dysregulated diseases; clinical research in the field of oncology; clinical research in the field of immuo-dysregulated diseases; research and development services in the field of anti-cancer preparations; research and development services in the field of preparations for treating immuno-dysregulated diseases; design, engineering, research, development and testing services in the field of oncology; design, engineering, research, development and testing services in the field of immuno-dysregulated diseases; providing information regarding medical research relating to oncology; providing information regarding medical research relating to immuno-dysregulated diseases
IMMIX BIOPHARMA
IMMIX BIOPHARMA
Service Mark
Word
REGISTERED
Owner:
Serial:97645177
Filed:Oct 24, 2022
Classes:42, 44
Registration:7234591
Registered:Dec 5, 2023
Goods & Services
Class 042: scientific research in the field of oncology; scientific research in the field of immuo-dysregulated diseases; development of pharmaceutical preparations and medicines for the treatment of cancer; development of pharmaceutical preparations and medicines for the treatment of immuno-dysregulated diseases; clinical research in the field of oncology; clinical research in the field of immuo-dysregulated diseases; research and development services in the field of anti-cancer preparations; research and development services in the field of preparations for treating immuno-dysregulated diseases; pharmaceutical drug design, product engineering, pharmaceutical research, pharmaceutical drug development and pharmaceutical product quality testing services for others in the field of oncology; pharmaceutical drug design, product engineering, pharmaceutical research, pharmaceutical drug development and pharmaceutical product quality testing services for others in the field of immuno-dysregulated diseases; providing information regarding medical research relating to oncology; providing information regarding medical research relating to immuno-dysregulated diseases; Class 044: providing medical information about the treatment of cancer; providing medical information about the treatment of immuno-dysregulated diseases; providing a website featuring healthcare and medical information, namely, information about cancer and the treatment of cancer; providing a website featuring healthcare and medical information, namely, information about immuno-dysregulated diseases and the treatment of immuno-dysregulated diseases
SMARXT TISSUE-SPECIFIC
ABANDONED
Owner:
Serial:90816261
Filed:Jul 7, 2021
Classes:5
TISSUE-SPECIFIC THERAPEUTICS (TSTX)
Owner:
Serial:90816280
Filed:Jul 7, 2021
Classes:5
Goods & Services
"THERAPEUTICS"
IMMIXBIO
IMMIXBIO
Trademark
Word
ABANDONED
Owner:
Serial:90813912
Filed:Jul 6, 2021
Classes:5
Goods & Services
Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Tumor suppressing agents
TME NORMALIZATION
TME NORMALIZATION
Trademark
Word
ABANDONED
Owner:
Serial:90813957
Filed:Jul 6, 2021
Classes:5

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.